Literature DB >> 26483048

Two cases of EGFR mutation-positive lung adenocarcinoma that transformed into squamous cell carcinoma: successful treatment of one case with rociletinib.

K Haratani1, H Hayashi2, S Watanabe1, H Kaneda3, T Yoshida1, M Takeda1, T Shimizu1, K Nakagawa1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26483048     DOI： 10.1093/annonc/mdv495

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

1.  Significant benefits of osimertinib in treating acquired resistance to first-generation EGFR-TKIs in lung squamous cell cancer: A case report.

Authors:  Yan Zhang; Hui-Min Chen; Yong-Mei Liu; Feng Peng; Min Yu; Wei-Ya Wang; Heng Xu; Yong-Sheng Wang; You Lu
Journal:  World J Clin Cases       Date:  2019-05-26       Impact factor: 1.337

Review 2.  Pathological transition as the arising mechanism for drug resistance in lung cancer.

Authors:  Yueqing Chen; Waiying Yvonne Tang; Xinyuan Tong; Hongbin Ji
Journal:  Cancer Commun (Lond)       Date:  2019-10-01

3.  GEAMP, a novel gastroesophageal junction carcinoma cell line derived from a malignant pleural effusion.

Authors:  Wei Zhang; Taylor A Williams; Ankur S Bhagwath; Jared S Hiermann; Craig D Peacock; D Neil Watkins; Peiguo Ding; Jason Y Park; Elizabeth A Montgomery; Arlene A Forastiere; Chunfa Jie; Brandi L Cantarel; Thai H Pham; David H Wang
Journal:  Lab Invest       Date:  2019-07-10       Impact factor: 5.662

Review 4.  Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung Cancer.

Authors:  Fiorella Calabrese; Federica Pezzuto; Francesca Lunardi; Francesco Fortarezza; Sofia-Eleni Tzorakoleftheraki; Maria Vittoria Resi; Mariaenrica Tiné; Giulia Pasello; Paul Hofman
Journal:  Int J Mol Sci       Date:  2022-04-09       Impact factor: 6.208

Review 5.  T790M mutation positive squamous cell carcinoma transformation from EGFR-mutated lung adenocarcinoma after low dose erlotinib: A case report and literature review.

Authors:  Yusaku Kusaba; Yuichiro Takeda; Sakurako Abe; Akinari Tsukada; Go Naka
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

6.  Histologic transformation from adenocarcinoma to both small cell lung cancer and squamous cell carcinoma after treatment with gefitinib: A case report.

Authors:  Yufeng Yao; Zhouyu Zhu; Yimin Wu; Ying Chai
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.